Physician profile
Ismail Tabash
NPI 1700167640
$11,829.61
in general payments reported to CMS, 2019-2025
21 companies · $633 in 2025
The $633 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,391 · 2022: $1,020 · 2023: $401 · 2024: $384 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258 · Travel and Lodging: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.29 |
| Travel and Lodging | $159.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,744.09 | 2021-2025 | In.Pact Av |
| Edwards Lifesciences Corporation | $1,582.43 | 2021 | |
| Abbott Laboratories | $1,020.84 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Boston Scientific Corporation | $387.74 | 2023-2025 | Watchman Access System, Rotapro, Avvigo Guidance System |
| Inari Medical, INC. | $211.53 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $130.11 | 2023-2024 | Impella |
| Penumbra, INC. | $125.95 | 2024 | Indigo System |
| Teleflex LLC | $112.63 | 2023 | Turnpike |
| Cordis US Corp. | $88.70 | 2021-2022 | |
| Philips North America LLC | $71.33 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $70.66 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.11 | 2021-2025 | Lifevest |
| Shockwave Medical, INC | $46.42 | 2022 | |
| Irhythm Technologies, INC. | $43.68 | 2023 | Zio Xt Patch |
| Cardiovascular Systems INC. | $29.68 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $20.81 | 2023 | Vitalpatch Rtm |
| Pfizer INC. | $20.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.16 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $17.32 | 2022 | |
| Merck Sharp & Dohme LLC | $15.05 | 2025 | Bridion |
| E.R. Squibb & Sons, L.L.C. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ismail Tabash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.